Evidence-based Chinese medicine for cancer therapy
- Publikationstyp:
- Zeitschriftenaufsatz
- Metadaten:
-
- Autoren
- V Badireenath Konkimalla
- Thomas Efferth
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000254767300001&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.jep.2007.12.009
- Externe Identifier
- Clarivate Analytics Document Solution ID: 285HG
- PubMed Identifier: 18243610
- ISSN
- 0378-8741
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- JOURNAL OF ETHNOPHARMACOLOGY
- Schlüsselwörter
- cancer therapy
- clinical trial
- meta-analysis
- molecular pharmacology
- pharmacognosy
- traditional Chinese medicine
- Paginierung
- 207 - 210
- Datum der Veröffentlichung
- 2008
- Status
- Published
- Titel
- Evidence-based Chinese medicine for cancer therapy
- Sub types
- Editorial Material
- Ausgabe der Zeitschrift
- 116
Datenquelle: Web of Science (Lite)
- Andere Metadatenquellen:
-
- Autoren
- V Badireenath Konkimalla
- Thomas Efferth
- DOI
- 10.1016/j.jep.2007.12.009
- ISSN
- 0378-8741
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- Journal of Ethnopharmacology
- Sprache
- en
- Paginierung
- 207 - 210
- Datum der Veröffentlichung
- 2008
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.jep.2007.12.009
- Datum der Datenerfassung
- 2019
- Titel
- Evidence-based Chinese medicine for cancer therapy
- Ausgabe der Zeitschrift
- 116
Datenquelle: Crossref
- Abstract
- In contrast to western medicine (WM), traditional Chinese medicine (TCM) does not focus on a single target but on multiple targets involved in a particular disease condition by applying diverse modalities, such as herbal medicine, acupuncture, moxibustion, etc. There is no pre-determined treatment procedure in TCM, and every patient condition is handled individually. Such patient-tailored treatments have a millennia-old tradition in TCM. Illustrative examples of the power of TCM have been documented in cancer research, i.e., camptothecin, homoharringtonine, or arsenic trioxide. On the other hand, one major reason for reluctance of western academia towards TCM is due to the lack of clinical studies of TCM receipts. This situation is changing very recently, and a number of clinical studies were conducted on TCM providing convincing evidence for the first time to gain credibility and reputation outside China. Clinical trials with TCM remedies focus on three major fields in cancer research: (1) improvement of poor treatment response rates towards standard chemo- and radiotherapy, (2) reduction of severe adverse effects of standard cancer therapy, and (3) unwanted interactions of standard therapy with herbal medicines. Efficacy and safety of TCM treatments depend on the quality of TCM products. Appropriate quality assurance and control of TCM products as well as sustainable production methods are pre-conditions for the implementation of TCM in cancer therapy at an international level. In conclusion, the most important question for recognition and implementation of TCM into WM concerns the clinical evidence for the efficacy of TCM and international quality standards for TCM products.
- Addresses
- German Cancer Research Centre, Pharmaceutical Biology (C015), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
- Autoren
- V Badireenath Konkimalla
- Thomas Efferth
- Thomas Efferth
- DOI
- 10.1016/j.jep.2007.12.009
- eISSN
- 1872-7573
- Externe Identifier
- PubMed Identifier: 18243610
- Open access
- false
- ISSN
- 0378-8741
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- Journal of ethnopharmacology
- Schlüsselwörter
- Humans
- Neoplasms
- Medicine, Chinese Traditional
- Evidence-Based Medicine
- Quality Control
- Herbal Medicine
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2007
- Paginierung
- 207 - 210
- Datum der Veröffentlichung
- 2008
- Status
- Published
- Datum der Datenerfassung
- 2008
- Titel
- Evidence-based Chinese medicine for cancer therapy.
- Sub types
- Research Support, Non-U.S. Gov't
- Journal Article
- Ausgabe der Zeitschrift
- 116
Datenquelle: Europe PubMed Central
- Abstract
- In contrast to western medicine (WM), traditional Chinese medicine (TCM) does not focus on a single target but on multiple targets involved in a particular disease condition by applying diverse modalities, such as herbal medicine, acupuncture, moxibustion, etc. There is no pre-determined treatment procedure in TCM, and every patient condition is handled individually. Such patient-tailored treatments have a millennia-old tradition in TCM. Illustrative examples of the power of TCM have been documented in cancer research, i.e., camptothecin, homoharringtonine, or arsenic trioxide. On the other hand, one major reason for reluctance of western academia towards TCM is due to the lack of clinical studies of TCM receipts. This situation is changing very recently, and a number of clinical studies were conducted on TCM providing convincing evidence for the first time to gain credibility and reputation outside China. Clinical trials with TCM remedies focus on three major fields in cancer research: (1) improvement of poor treatment response rates towards standard chemo- and radiotherapy, (2) reduction of severe adverse effects of standard cancer therapy, and (3) unwanted interactions of standard therapy with herbal medicines. Efficacy and safety of TCM treatments depend on the quality of TCM products. Appropriate quality assurance and control of TCM products as well as sustainable production methods are pre-conditions for the implementation of TCM in cancer therapy at an international level. In conclusion, the most important question for recognition and implementation of TCM into WM concerns the clinical evidence for the efficacy of TCM and international quality standards for TCM products.
- Date of acceptance
- 2007
- Autoren
- V Badireenath Konkimalla
- Thomas Efferth
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/18243610
- DOI
- 10.1016/j.jep.2007.12.009
- ISSN
- 0378-8741
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- J Ethnopharmacol
- Schlüsselwörter
- Evidence-Based Medicine
- Herbal Medicine
- Humans
- Medicine, Chinese Traditional
- Neoplasms
- Quality Control
- Sprache
- eng
- Country
- Ireland
- Paginierung
- 207 - 210
- PII
- S0378-8741(07)00690-3
- Datum der Veröffentlichung
- 2008
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2008
- Titel
- Evidence-based Chinese medicine for cancer therapy.
- Sub types
- Journal Article
- Research Support, Non-U.S. Gov't
- Ausgabe der Zeitschrift
- 116
Datenquelle: PubMed
- Beziehungen:
- Eigentum von